224810
224810 operates in various business sectors.
224810 (224810) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, 224810 (224810) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
224810 - Net Assets Trend (None–None)
This chart illustrates how 224810's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 224810 (None–None)
The table below shows the annual net assets of 224810 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to 224810's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
224810 Competitors by Market Cap
The table below lists competitors of 224810 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VisionWave Holdings, Inc. Warrant
NASDAQ:VWAVW
|
$14.59K |
|
Propellus Inc
PINK:PRPS
|
$14.60K |
|
CASI PHARMAC. NEW O.N.
F:ENM
|
$14.61K |
|
Eureka Capital Corp.
V:EBCD-P
|
$14.62K |
|
CanaFarma Hemp Products Corp
PINK:CNFHF
|
$14.56K |
|
CHINA OVS LD & INV
MU:CPP
|
$14.54K |
|
NATIONAL INVESTMENT COMPANY LIMITED
DSE:NICO
|
$14.53K |
|
Trufin PLC
LSE:TRU
|
$14.52K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 224810's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares 224810's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently 224810 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares 224810's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.